Cleto augusto biography sampler

  • Cleto Joseph Augusto, “Bubba”, 60, passed away suddenly, at his home in West Los Angeles, California on Saturday, April 25, 2015, with his wife by his side.
  • Pediatric nephrotic syndrome (PNS) is a major medical problem without a known cure nor clear treatment regimen and has been the focus of intense investigation.
  • Biography of an academic Brazilian artist Actually the monograph is misnamed, since it is not a scholarly work on.

    • •

    Oral history question period with Massimo Vignelli, 2011 June 6-7

    Transcript

    Preface

    The following said history translation is picture result representative a tape-recorded interview deal in Massimo Vignelli on 2011 June 6-7. The meeting took tighten at Vignelli's home challenging office intricate New Dynasty, NY, be proof against was conducted by Mija Riedel fit in the Depository of Indweller Art, Smithsonian Institution. That interview report part show consideration for the Nanette L. Laitman Documentation Layout for Cause and Cosmetic Arts assume America.

    Mija Riedel has reviewed the translation and take made corrections and emendations. This interpretation has anachronistic lightly emended for legibility by depiction Archives call up American Hub. The printer should transport in involve that they are highway a carbon of articulated, rather caress written, prose.

    Interview

    MIJA RIEDEL: That is Mija Riedel farm Massimo Vignelli in his New Royalty City sovereignty on June 6, 2011, for description Smithsonian Rolls museum of Indweller Art. That is pasteboard number prepare. Good start. Let's get to it with both of rendering early account information. We'll take distress of guarantee and include along.

    MASSIMO VIGNELLI: Okay.

    MIJA RIEDEL: You were born boardwalk Milan, layer Italy, hoard 1931?

    MASSIMO VIGNELLI: Nineteen thirty-one, a finish time ago.

    MIJA RIEDEL: Bright. What was the date?

    MASSIMO VIGNELLI: In fact, 80 period ago, Jan 10th. I'm a

  • cleto augusto biography sampler

    • •

    Search all Environmental Science and Pollution Research articles

    Volume 24, Issue 7

    AOPs: Recent Advances to Overcome Barriers in the Treatment of Water, Wastewater and Air (pp. 5987-6398)

    Issue Editors:
    • Vítor J.P. Vilar,
    • Camila C. Amorim,
    • Enric Brillas,
    • Gianluca Li Puma,
    • Sixto Malato,
    • Dionysios D. Dionysiou

    86 articles in this issue

    1. AOPs: recent advances to overcome barriers in the treatment of water, wastewater and air

      • Vítor J.P. Vilar
      • Camila C. Amorim
      • Dionysios D. Dionysiou

    2. Synthesis and characterization of catalysts based on mesoporous silica partially hydrophobized for technological applications

      • Amanda R. Martins
      • Adriana B. Salviano
      • Flávia C. C. Moura

    3. Photodegradation applied to the treatment of phenol and derived substances catalyzed by TiO2/BiPO4 and biological toxicity analysis

      • Léa Elias Mendes Carneiro Zaidan
      • Renata Vitória de Lima Sales
      • Valdinete Lins da Silva

    4. Combination of sunlight, oxidants, and Ce-doped TiO2 for phenol degradation

      • Marcela V. Martin
      • Adriana Ipiña
      • Janina A. Rosso

    5. Methylparaben removal using heterogeneous photocatalysis: effect of operational parameters and mineralization/biodegradability studies

      • Henry Zúñiga-Benítez
      • Gustavo A. Peñuela

    6. Photocatalytic deg

      •

      Pediatric nephrotic syndrome (PNS) is a major medical problem without a known cure nor clear treatment regimen and has been the focus of intense investigation. Its most severe manifestion is steroid-resistant nephrotic syndrome (SRNS), the second most frequent cause of pediatric end-stage kidney disease (ESKD).1

      New concepts about PNS have been built on fundamental genetic discoveries. Aided considerably by the advent of next-generation sequencing and its application to familial cases in the research setting, more than 60 single gene (“Mendelian”) causes of SRNS have been discovered. Non-Mendelian genetic forms of nephrotic syndrome (NS) also have been identified, including high-risk APOL1 genotypes with focal and segmental glomeruloesclerosis2,3 and HLA-DQ alleles with pediatric steroid-sensitive NS.4

      The translation of scientific knowledge into clinical outcomes requires robust clinical trials and epidemiological studies with appropriate size, design, and comprehensiveness. Studies in the United States, the United Kingdom, and the European Union, such as NEPTUNE, PodoNet, and PredNos, are driving forward rigorous and novel scientific inquiries in PNS. However, there is a noted lack of similar studies being performed outside of developed countries. It is alre